Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2016	Jun. 30, 2016
Current assets:
Cash and cash equivalents	$ 86.9	$ 68.5
Marketable investment securities	61.5	90.5
Prepaid expenses	12.2	18.4
Inventory	53.9	38.3
Trade accounts receivable, less allowance for doubtful accounts of $6.8 September 30, 2016 and $6.8 June 30, 2016	98.2	91.7
Prepaid taxes	5.6	3.8
Other receivables	4.6	3.3
Total current assets	322.9	314.5
Property, plant and equipment, net	56.8	58.3
Long-term marketable investment securities	52.2	79.9
Intangibles, net	521.2	227.5
Goodwill	312.8	195.3
Other assets	5.0	5.0
Total assets	1,270.9	880.5
Current liabilities:
Accounts payable	19.9	21.1
Accrued liabilities	54.8	49.5
Short-term debt	199.2
Deferred revenue	1.0	1.7
Total current liabilities	274.9	72.3
Unrecognized tax benefits	24.4	24.0
Other long-term liabilities	148.7	18.2
Long-term deferred taxes	87.6	17.9
Total liabilities	535.6	132.4
Commitments and contingencies
Stockholders' equity:
Common stock, 68.4 and 69.1 shares outstanding at September 30, 2016 and June 30, 2016 respectively	0.7	0.7
Additional paid-in capital	826.9	830.1
Accumulated other comprehensive loss	(5.6)	(9.5)
Accumulated deficit	(86.5)	(73.2)
Total Myriad Genetic, Inc. stockholders' equity	735.5	748.1
Non-Controlling Interest	(0.2)
Total stockholders' equity	735.3	748.1
Total liabilities and stockholders' equity	$ 1,270.9	$ 880.5

Prepaid expense excluding prepaid taxes current.

No definition available.

Name:	mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent
Namespace Prefix:	mygn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).